FEELTECT

FEELTECT is an Ireland-based connected health wound care company. The company's primary mission is to address unmet critical needs in order to significantly reduce healing time and the workload on healthcare professionals in VLU treatment, improve patients' quality of life, and lower treatment costs. Since its spin-off from the University of Galway in 2020, FEELTECT has achieved many milestone accomplishments, including FDA registration in the United States, EUDMED registration in Europe, ISO 13485 certification, preliminary clinical validation, international patents for hardware and software technology, and completion of design for manufacturing. The company is about to launch a €4.6 million Disruptive Technologies Innovation Fund collaborative project to expand its product line and ultimately develop the first data-driven clinical decision support system, revolutionizing wound care.